Jamieson completed his PhD in the laboratory of Prof. Rob Moore at RMIT University, where he investigated Campylobacter glycobiology and vaccine development. In 2025, he joined King’s College London to establish a Shigella infection model using human induced pluripotent stem cell-derived macrophages, to uncover the mechanisms underlying Shigella persistent infections.